Israel Innovation Authority logo
Israel Innovation Authority

IIA Magnet Consortium R&D

Supports pre-competitive technology infrastructure work through Israeli industry and research consortium cooperation.

OpenIsrael Innovation AuthorityIsrael

The Israel Innovation Authority's Magnet program funds pre-competitive, multi-partner R&D consortia that bring together Israeli industrial companies and Israeli academic research institutions to develop generic technology infrastructure of broad strategic value. A qualifying consortium typically includes three or more Israeli industrial companies and at least one Israeli academic partner, working …

Pre-competitive generic technology infrastructure of broad value to Israeli industry. Multi-partner consortium R&D across all sectors.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.28 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.33%
Funding pooliThe total budget available across all awards in this round.₪200M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Scheduled

Clinical Research for Common Cancers

🇪🇺European Commission · European Union

Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.

MedtechBiotech+1
€7M – €10MSep'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

🇪🇺European Commission · European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
€8M – €10MApr'27
European Commission logo
Scheduled

Pre-Commercial Procurement for Cancer Care

🇪🇺European Commission · European Union

Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.

MedtechBiotech+1
€8M – €10MSep'27
European Commission logo
Closed

Robust and trustworthy GenerativeAI for Robotics and industrial automation (RIA) (AI/Data/Robotics & Made in Europe Partnerships)

🇮🇸European Commission · European Union

Funds two projects, worth up to EUR 45 million each, to build generative AI foundation models for robotics or manufacturing, with at least EUR 10 million of each project re-granted to third-party companies.

RoboticsAdvanced Manufacturing+1
€40M – €45M
European Commission logo
Scheduled

Human-AI Collaboration for Future Manufacturing

🇪🇺European Commission · European Union

Funds €4–6M projects that make human-AI collaboration more inclusive, adaptable and effective on the factory floor.

Advanced ManufacturingAI+2
€4M – €6MFeb'27
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27